Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

PERRIGO COMPANY PLC (PRGO)

Pharmaceutical Preparations

https://www.perrigo.com

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

THE SHARP BUILDING, HOGAN PLACE
DUBLIN 2, L2

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/16/1991

Market Cap

3,750,048,350

Shares Outstanding

135,510,000

Weighted SO

135,506,489

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

PBH --.--%

AMPH --.--%

DCPH --.--%

PCRX --.--%

COLL --.--%

PAHC --.--%

ELAN --.--%

RDY --.--%

SSIC --.--%

Beta

0.5100

Last Div

1.1000

Range

24.82-38.42

Chg

-0.0700

Avg Vol

1625200

Mkt Cap

3750048350

Exch

NYSE

Country

IE

Phone

353 1 709 4000

DCF Diff

-55.1969

DCF

82.9519

Div Yield

0.0399

P/S

0.8468

EV Multiple

12.1607

P/FV

0.8292

Div Yield %

3.9942

P/E

-31.4860

PEG

-0.3486

Payout

-1.2682

Current Ratio

1.9885

Quick Ratio

1.2384

Cash Ratio

0.3648

DSO

61.9446

DIO

143.6019

Op Cycle

205.5465

DPO

60.6597

CCC

144.8869

Gross Margin

0.3594

Op Margin

0.0304

Pretax Margin

-0.0469

Net Margin

-0.0270

Eff Tax Rate

0.4516

ROA

-0.0115

ROE

-0.0256

ROCE

0.0151

NI/EBT

0.5763

EBT/EBIT

-1.5408

EBIT/Rev

0.0304

Debt Ratio

0.3918

D/E

0.8963

LT Debt/Cap

0.4423

Total Debt/Cap

0.4727

Int Coverage

0.7778

CF/Debt

0.0838

Equity Multi

2.2875

Rec Turnover

5.8924

Pay Turnover

6.0172

Inv Turnover

2.5417

FA Turnover

3.9798

Asset Turnover

0.4259

OCF/Share

2.4894

FCF/Share

1.6725

Cash/Share

3.9592

OCF/Sales

0.0771

FCF/OCF

0.6718

CF Coverage

0.0838

ST Coverage

0.7265

CapEx Coverage

3.0473

Div&CapEx Cov

1.2938

P/BV

0.8292

P/B

0.8292

P/S

0.8468

P/E

-31.4860

P/FCF

16.3543

P/OCF

11.0427

P/CF

11.0427

PEG

-0.3486

P/S

0.8468

EV Multiple

12.1607

P/FV

0.8292

DPS

1.0980

Latest Headlines (EST)

GlobeNewswire Inc. Sep 13, 00:15 Nicotine Replacement Products Market Size to Reach USD 4.6 Billion by 2033, Says The Brainy Insights MarketWatch Dec 30, 07:02 20 midcap stocks with 2024 upside ranging up to 62%, according to analysts MarketWatch Dec 26, 13:02 20 midcap stocks with 2024 upside ranging up to 62%, according to analysts MarketWatch Dec 26, 13:02 20 midcap stocks with 2024 upside ranging up to 62%, according to analysts Seeking Alpha Nov 27, 00:43 Dividend Champion, Contender, And Challenger Highlights: Week Of November 26 Benzinga Nov 17, 14:54 Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks Zacks Investment Research Nov 02, 17:25 Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.28 05/31/2024 05/01/2024 05/31/2024 06/18/2024
0.28 03/07/2024 02/26/2024 03/08/2024 03/26/2024
0.27 11/30/2023 11/02/2023 12/01/2023 12/19/2023
0.27 08/31/2023 08/02/2023 09/01/2023 09/19/2023
0.27 06/01/2023 05/04/2023 06/02/2023 06/20/2023
0.27 03/09/2023 02/21/2023 03/10/2023 03/28/2023
0.26 12/01/2022 11/03/2022 12/02/2022 12/20/2022
0.26 09/01/2022 08/02/2022 09/02/2022 09/20/2022
0.26 06/02/2022 05/05/2022 06/03/2022 06/21/2022
0.26 02/25/2022 02/16/2022 02/28/2022 03/17/2022
0.24 12/02/2021 11/02/2021 12/03/2021 12/21/2021
0.24 09/02/2021 08/03/2021 09/03/2021 09/21/2021
0.24 06/03/2021 04/19/2021 06/04/2021 06/22/2021
0.24 03/11/2021 02/23/2021 03/12/2021 03/30/2021
0.22 11/25/2020 10/22/2020 11/27/2020 12/15/2020
0.22 08/27/2020 07/29/2020 08/28/2020 09/15/2020
0.22 05/28/2020 05/05/2020 05/29/2020 06/16/2020
0.22 02/27/2020 02/18/2020 02/28/2020 03/17/2020
0.21 11/27/2019 11/04/2019 11/29/2019 12/17/2019
0.21 08/29/2019 07/31/2019 08/30/2019 09/17/2019
0.21 05/30/2019 04/26/2019 05/31/2019 06/18/2019
0.19 02/28/2019 02/14/2019 03/01/2019 03/19/2019
0.19 11/29/2018 10/31/2018 11/30/2018 12/18/2018
0.19 08/30/2018 08/01/2018 08/31/2018 09/18/2018
0.19 05/31/2018 05/03/2018 06/01/2018 06/19/2018
0.19 03/01/2018 02/15/2018 03/02/2018 03/20/2018
0.16 11/30/2017 11/02/2017 12/01/2017 12/19/2017
0.16 08/23/2017 08/08/2017 08/25/2017 09/12/2017
0.16 05/24/2017 05/03/2017 05/26/2017 06/13/2017
0.16 03/01/2017 02/21/2017 03/03/2017 03/21/2017
0.14 11/22/2016 11/08/2016 11/25/2016 12/13/2016
0.14 08/24/2016 08/02/2016 08/26/2016 09/13/2016
0.14 05/25/2016 04/26/2016 05/27/2016 06/14/2016
0.14 02/24/2016 02/16/2016 02/26/2016 03/15/2016
0.12 11/24/2015 11/04/2015 11/27/2015 12/15/2015
0.12 08/26/2015 08/12/2015 08/28/2015 09/15/2015
0.12 05/27/2015 04/28/2015 05/29/2015 06/16/2015
0.12 02/25/2015 01/27/2015 02/27/2015 03/17/2015
0.10 11/25/2014 11/03/2014 11/28/2014 12/16/2014
0.10 08/27/2014 08/13/2014 08/29/2014 09/16/2014
0.10 05/28/2014 04/28/2014 05/30/2014 06/17/2014
0.10 02/26/2014 01/29/2014 02/28/2014 03/18/2014
0.01 12/19/2013 12/12/2013 12/19/2013 02/01/2014
0.09 11/26/2013 11/06/2013 11/29/2013 12/17/2013
0.09 08/28/2013 08/14/2013 08/30/2013 09/17/2013
0.09 05/29/2013 05/02/2013 05/31/2013 06/18/2013
0.09 02/27/2013 01/31/2013 03/01/2013 03/19/2013
0.09 11/27/2012 11/06/2012 11/29/2012 12/17/2012
0.08 08/29/2012 08/15/2012 08/31/2012 09/18/2012
0.08 05/30/2012 05/03/2012 06/01/2012 06/19/2012
0.08 02/29/2012 02/02/2012 03/02/2012 03/20/2012
0.08 11/22/2011 10/26/2011 11/25/2011 12/13/2011
0.07 08/24/2011 08/11/2011 08/26/2011 09/13/2011
0.07 05/25/2011 04/28/2011 05/27/2011 06/14/2011
0.07 02/23/2011 01/26/2011 02/25/2011 03/15/2011
0.07 11/23/2010 10/27/2010 11/26/2010 12/14/2010
0.06 08/25/2010 08/11/2010 08/27/2010 09/14/2010
0.06 05/26/2010 04/28/2010 05/28/2010 06/15/2010
0.06 02/24/2010 01/27/2010 02/26/2010 03/16/2010
0.06 11/24/2009 10/29/2009 11/27/2009 12/15/2009
0.06 08/26/2009 08/13/2009 08/28/2009 09/15/2009
0.06 05/27/2009 05/06/2009 05/29/2009 06/16/2009
0.06 02/25/2009 01/28/2009 02/27/2009 03/17/2009
0.06 11/25/2008 11/04/2008 11/28/2008 12/16/2008
0.05 08/20/2008 08/13/2008 08/22/2008 09/16/2008
0.05 05/21/2008 05/01/2008 05/25/2008 06/20/2008
0.05 02/20/2008 02/01/2008 02/22/2008 03/18/2008
0.05 11/20/2007 10/30/2007 11/23/2007 12/18/2007
0.04 08/22/2007 08/16/2007 08/24/2007 09/18/2007
0.04 05/23/2007 05/02/2007 05/25/2007 06/19/2007
0.04 02/21/2007 02/08/2007 02/23/2007 03/20/2007
0.04 11/21/2006 11/10/2006 11/24/2006 12/19/2006
0.04 08/23/2006 08/11/2006 08/25/2006 09/19/2006
0.04 05/24/2006 05/12/2006 05/26/2006 06/20/2006
0.04 02/22/2006 02/15/2006 02/24/2006 03/21/2006
0.04 11/22/2005 10/28/2005 11/25/2005 12/20/2005
0.04 08/24/2005 08/05/2005 08/26/2005 09/20/2005
0.04 05/25/2005 04/22/2005 05/27/2005 06/21/2005
0.04 02/23/2005 02/04/2005 02/25/2005 03/22/2005
0.04 11/23/2004 10/29/2004 11/26/2004 12/21/2004
0.04 08/25/2004 08/06/2004 08/27/2004 09/21/2004
0.04 05/26/2004 04/30/2004 05/28/2004 06/22/2004
0.04 02/25/2004 01/30/2004 02/27/2004 03/23/2004
0.04 11/25/2003 10/28/2003 11/28/2003 12/23/2003
0.02 08/27/2003 08/07/2003 08/29/2003 09/23/2003
0.02 05/28/2003 05/09/2003 05/30/2003 06/24/2003
0.02 02/26/2003 01/23/2003 02/28/2003 03/21/2003